143 related articles for article (PubMed ID: 1692487)
1. Fludarabine therapy in macroglobulinemic lymphoma.
Kantarjian HM; Alexanian R; Koller CA; Kurzrock R; Keating MJ
Blood; 1990 May; 75(10):1928-31. PubMed ID: 1692487
[TBL] [Abstract][Full Text] [Related]
2. 2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
Dimopoulos MA; Weber DM; Kantarjian H; Keating M; Alexanian R
Ann Oncol; 1994 Mar; 5(3):288-9. PubMed ID: 7514439
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
McLaughlin P; Robertson LE; Keating MJ
Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
[No Abstract] [Full Text] [Related]
4. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer.
Mittelman A; Savona S; Puccio C; Chun H; Ahmed T; Feldman E; Sullivan P; Arnold P; Arlin Z
Invest New Drugs; 1990; 8 Suppl 1():S65-7. PubMed ID: 1696246
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
7. Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma.
Ajani JA; Abbruzzese JL; Faintuch JS; Blackburn R; Levin B; Boman BM
Invest New Drugs; 1988 Apr; 6(1):47-50. PubMed ID: 2457566
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fludarabine phosphate in small cell carcinoma. A Southwest Oncology Group Study.
Rainey JM; Hill JB; Crowley J
Invest New Drugs; 1988 Apr; 6(1):45-6. PubMed ID: 2457565
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
[No Abstract] [Full Text] [Related]
10. Evaluation of fludarabine phosphate in patients with recurrent glioma.
Cascino TL; Brown LD; Morton RF; Everson LK; Marschke RF; Dinapoli RP; O'Fallon JR
Am J Clin Oncol; 1988 Oct; 11(5):586-8. PubMed ID: 2459951
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
Kraut EH; Crowley JJ; Grever MR; Keppen MD; Bonnet JD; Hynes HE; Salmon SE
Invest New Drugs; 1990 May; 8(2):199-200. PubMed ID: 1696569
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
[No Abstract] [Full Text] [Related]
14. Fludarabine phosphate therapy in other lymphoid malignancies.
Kantarjian HM; Redman JR; Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
[TBL] [Abstract][Full Text] [Related]
16. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
Von Hoff DD; Dahlberg S; Hartstock RJ; Eyre HJ
J Natl Cancer Inst; 1990 Aug; 82(16):1353-5. PubMed ID: 1696322
[No Abstract] [Full Text] [Related]
17. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Binet JL
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine phosphate. Phase II evaluation in advanced soft-tissue sarcomas.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Aug; 10(4):341-3. PubMed ID: 2441592
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
Carpenter JT; Vogel CL; Wang G; Raney M
Cancer Treat Rep; 1986 Oct; 70(10):1235-6. PubMed ID: 2428493
[No Abstract] [Full Text] [Related]
20. Phase I study of fludarabine (2-fluoro-ara-AMP).
Kavanagh JJ; Krakoff IH; Bodey GP
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1009-11. PubMed ID: 2415365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
